Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro

Yoon Woo Koh(Yonsei University), Matthew D. Ringel(The Ohio State University Wexner Medical Center)
Endocrine Related Cancer
November 22, 2011
Cited by 37


Related Papers